Procaps Group, S.A. (PROCW) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Jan 21Feb 3Nov 25Mar 2Mar 10Mar 13Mar 18Mar 23

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

2.3x

Market Cap

$1.99M

MomentumView details →

1D Return

+33.79%

YTD Return

—

RSI (14)

38.8

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

2.3x

Market Cap

$1.99M

RSI (14)

38.8

MomentumView details →

1D Return

+33.79%

YTD Return

—

ProfitabilityView details →

Gross Margin

55.04%

Net Margin

12.61%

EBITDA Margin

29.04%

ROE (TTM)

132.54%

ROA (TTM)

10.47%

Asset Turnover

0.84x

GrowthView details →

Revenue YoY

−4.80%

EPS YoY

+425.00%

FCF YoY

+96.90%

Revenue CAGR 3Y

+8.07%

EPS CAGR 3Y

+140.78%

EBITDA YoY

+1560.40%

EarningsView details →

EPS (Actual)

—

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Capital & dividendView details →

Debt/Equity

7.36x

Current Ratio

1.47x

Quick Ratio

0.99x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

Financials snapshotView financials →

Revenue (TTM)

414.10M

Net Income (TTM)

52.20M

Op. CF (TTM)

62.99M

Latest newsMore news →

No recent news for PROCW.

Similar companies

Akanda Corp.AKAN IM Cannabis Corp.IMCC China SXT Pharmaceuticals, Inc.SXTC PRF Technologies Ltd.PRFX Shuttle Pharmaceuticals Holdings, Inc.SHPH RedHill Biopharma Ltd.RDHL Find similar companies →

Latest newsMore news →

No recent news for PROCW.